Status:
COMPLETED
Effects of Monarda Didyma Extract Supplementation on Biological Ageing
Lead Sponsor:
Sofia Pavanello
Collaborating Sponsors:
Mibelle AG
Conditions:
Aging
Eligibility:
All Genders
45-65 years
Phase:
NA
Brief Summary
This research aims to explore the potential benefits of supplementation of a natural ingredient, the Monarda didyma extract, to reduce / delay the biological aging of a susceptible population, thus co...
Eligibility Criteria
Inclusion
- The subject is able and willing to follow the study protocol procedures to sign the Informed Consent Form prior to screening evaluations
- Age: 45 - 65
Exclusion
- Relevant history or presence of any medical disorder potentially interfering with this study (heavy depression, diabetes, active cancer, severe liver disease, heavy cardiovascular disease (e.g., stroke, heart attack))
- Chronic intake of medication/dietary supplements with impact on stress levels (psychologically and physiological)
- Consumption of any dietary/nutritional supplements or functional foods
- Smokers
- High caffeine intake \> 5 coffee cups / day
- Gastrointestinal diseases/conditions (ulcerative colitis, Crohn's disease, peptic ulcers, celiac disease)
- Drug-, alcohol- and medication abuses
- Known HIV-infection
- Known acute or chronic hepatitis B and C infection
- Known allergies against the mint family (labiate), especially lemon balm (la cedrella, la melissa, la citronella)
- Pregnancy, breastfeeding or intention to become pregnant during the study
- Participation in another clinical study within the last 4 weeks and concurrent participation in another clinical study
- Blood donation within 4 weeks prior to study start (screening) or during the study
- Anticipating any planned changes in lifestyle for the duration of the study
- Subjects considered inappropriate for the study by investigators, including subjects who are unable or unwilling to show compliance with the protocol
Key Trial Info
Start Date :
February 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2024
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT05399966
Start Date
February 28 2023
End Date
January 30 2024
Last Update
June 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedale Università Padova
Padua, PD, Italy, 35128